Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Triazolyl- vs Pyridyl-Functionalized N-Heterocyclic Carbene Complexes: Impact of the Pendant N-Donor Ligand on Intramolecular C-C Bond Formation. | ACS Org Inorg Au | 2022 | 36510612 | PubTator, text mining | PubMed |
| Role of Ceramides and Lysosomes in Extracellular Vesicle Biogenesis, Cargo Sorting and Release. | Int J Mol Sci | 2022 | 36499644 | PubTator, text mining | PubMed |
| Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance. | Int J Mol Sci | 2022 | 36499561 | PubTator, text mining | PubMed |
| Progress in Anticancer Drug Development Targeting Ubiquitination-Related Factors. | Int J Mol Sci | 2022 | 36499442 | PubTator, text mining | PubMed |
| Insights into the Role of Sialylation in Cancer Metastasis, Immunity, and Therapeutic Opportunity. | Cancers (Basel) | 2022 | 36497322 | PubTator, text mining | PubMed |
| The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations. | Cells | 2022 | 36497078 | PubTator, text mining | PubMed |
| Immunomodulatory role of metalloproteinase ADAM17 in tumor development. | Front Immunol | 2022 | 36466812 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of the tumor ecosystem of adenoid cystic carcinoma. | Front Oncol | 2022 | 36465348 | PubTator, text mining | PubMed |
| Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma. | Cancer Manag Res | 2022 | 36452435 | PubTator, text mining | PubMed |
| Future perspective of stem cell-derived exosomes: Cell-free therapeutic strategies for retinal degeneration. | Front Bioeng Biotechnol | 2022 | 36452207 | PubTator, text mining | PubMed |
| Application of comprehensive pharmaceutical care program in identifying and addressing drug-related problems in hospitalized patients with osteoporosis. | BMC Health Serv Res | 2022 | 36443812 | PubTator, text mining | PubMed |
| Decorin promotes decidual M1-like macrophage polarization via mitochondrial dysfunction resulting in recurrent pregnancy loss. | Theranostics | 2022 | 36438479 | PubTator, text mining | PubMed |
| Extracellular signals regulate the biogenesis of extracellular vesicles. | Biol Res | 2022 | 36435789 | PubTator, text mining | PubMed |
| Lectin-Based Study Reveals the Presence of Disease-Relevant Glycoepitopes in Bladder Cancer Cells and Ectosomes. | Int J Mol Sci | 2022 | 36430846 | PubTator, text mining | PubMed |
| Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes. | Cancers (Basel) | 2022 | 36428749 | PubTator, text mining | PubMed |
| Contemporary Clinical Definitions, Differential Diagnosis, and Novel Predictive Tools for Renal Cell Carcinoma. | Biomedicines | 2022 | 36428491 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies. | J Interv Cardiol | 2022 | 36419957 | PubTator, text mining | PubMed |
| High-precision estimation of emitter positions using Bayesian grouping of localizations. | Nat Commun | 2022 | 36418347 | PubTator, text mining | PubMed |
| Cancer incidence and mortality in Quito: information to monitor cancer control policies. | Colomb Med (Cali) | 2022 | 36415599 | PubTator, text mining | PubMed |
| Extracellular vesicles biogenesis, isolation, manipulation and genetic engineering for potential in vitro and in vivo therapeutics: An overview. | Front Bioeng Biotechnol | 2022 | 36406206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=30